Fresenius Medical Care

Yahoo Finance • 23 days ago

RIS Rx Appoints Stuart McGuigan to Board of Directors

IRVINE, Calif., December 17, 2025--(BUSINESS WIRE)--RIS Rx, a healthcare technology company offering gross-to-net (GTN) revenue protection and saving more than $1 billion for the world’s leading pharmaceutical manufacturers, today announce... Full story

Yahoo Finance • 25 days ago

Liberty All-Star® Equity Fund November 2025 Monthly Update

BOSTON, December 15, 2025--(BUSINESS WIRE)--Below is the November 2025 Monthly Update for the Liberty All-Star Equity Fund (NYSE: USA). Liberty All-Star Equity Fund Ticker: USA Monthly Update, November 2025 Investment Approach: Fund... Full story

Yahoo Finance • last month

Focus Graphite Appoints Renowned Battery Executive Dr. Sunho Kang as Strategic Advisor for Cell Technology

Former Apple and Samsung SDI Battery Expert to Guide High-Purity Anode Materials and Dual-Use Next-Generation Cell Platforms. Ottawa, Ontario--(Newsfile Corp. - December 3, 2025) - Focus Graphite Inc. (TSXV: FMS) (OTCQB: FCSMF) (FSE: FKC0... Full story

Yahoo Finance • 2 months ago

Liberty All-Star® Equity Fund October 2025 Monthly Update

BOSTON, November 14, 2025--(BUSINESS WIRE)--Below is the October 2025 Monthly Update for the Liberty All-Star Equity Fund (NYSE: USA). Liberty All-Star Equity Fund Ticker: USA Monthly Update, October 2025 Investment Approach: Fund Style... Full story

Yahoo Finance • 3 months ago

Lockheed Martin secures $610 million U.S. Navy contract modification

* Lockheed Martin (NYSE:LMT [https://seekingalpha.com/symbol/LMT]) is awarded a $610 million modification to a previously awarded fixed-price incentive, undefinitized, advanced acquisition contract. * This modification adds scope to pr... Full story

Yahoo Finance • 3 months ago

FMS Crosses Below Key Moving Average Level

In trading on Wednesday, shares of Fresenius Medical Care (Symbol: FMS) crossed below their 200 day moving average of $20.00, changing hands as low as $19.45 per share. Fresenius Medical Care shares are currently trading down about 4.6% o... Full story

Yahoo Finance • 5 months ago

Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum

On Monday, the U.S. Food and Drug Administration (FDA) approved Amphastar Pharmaceuticals, Inc.’s (NASDAQ:AMPH) Abbreviated New Drug Application (ANDA) for Iron Sucrose Injection, USP 50mg/2.5mL, 100mg/5mL, and 200mg/10mL in single-dose vi... Full story

Yahoo Finance • 5 months ago

Fresenius Medical Care launches €600 million share buyback tranche

BAD HOMBURG, Germany - Fresenius Medical Care (FME), a provider of products and services for individuals with renal diseases, announced Monday the launch of the first tranche of its share buyback program worth up to €600 million. The compa... Full story

Yahoo Finance • 5 months ago

FMS Makes Notable Cross Below Critical Moving Average

In trading on Monday, shares of Fresenius Medical Care (Symbol: FMS) crossed below their 200 day moving average of $20.10, changing hands as low as $19.66 per share. Fresenius Medical Care shares are currently trading off about 4.3% on th... Full story

Yahoo Finance • 5 months ago

Frenova, Nephronomics and GENEWIZ collaborate on kidney disease research

BAD HOMBURG, Germany - Fresenius Medical Care announced Thursday that its research organization Frenova has partnered with Nephronomics and GENEWIZ by Azenta Life Sciences to advance genomic analysis for kidney disease research. The colla... Full story

Yahoo Finance • 6 months ago

Fresenius Medical Care AG (FMS) Partners With Mexico’s Coordination of National Institutes of Health and Specialty Hospitals

Fresenius Medical Care AG (NYSE:FMS) is one of the 13 Best German Stocks to Invest in Now. On July 3, the company announced it had partnered with Mexico’s Coordination of National Institutes of Health and Specialty Hospitals (CCINSHAE) to... Full story

Yahoo Finance • 7 months ago

Opterion Health AG Appoints Industry Leaders Rice Powell and Mark Hahn to Board of Directors

Opterion Health AG MUTTENZ, Switzerland, June 23, 2025 (GLOBE NEWSWIRE) -- Opterion Health AG, a Swiss-based life sciences company developing a next-generation, non-glucose based peritoneal dialysis (PD) solution, today announced the appo... Full story

Yahoo Finance • 7 months ago

Fresenius Medical Care price target raised to €56 on medium-term outlook

BofA Securities raised its price target on Fresenius Medical Care AG & Co KGaA (FME:GR) (NYSE:FMS) to €56.00 from €55.00 while maintaining a Neutral rating. The adjustment follows the company’s Capital Markets Day held in London on Tuesday... Full story

Yahoo Finance • 7 months ago

Bernstein raises Fresenius Medical Care price target on restructuring progress

Bernstein SocGen Group raised its price target on Fresenius Medical Care (NYSE:FMS), a prominent $15.3 billion healthcare provider with a "GOOD" financial health rating according to InvestingPro, to $31.50 from $26.00 on Wednesday, while m... Full story

Yahoo Finance • 7 months ago

Fresenius Medical Care initiates €1B share buyback

[Stock buyback concept. Corporate action in which a company buys back its own shares from the open market or from its shareholders. Notes in the hands of a businessman and a piggy bank] Fresenius Medical Care (NYSE:FMS [https://seekingalp... Full story

Yahoo Finance • 7 months ago

Fresenius Medical Care Reveals FME Reignite Strategy; Announces EUR 1 Bln Share Buyback

(RTTNews) - Fresenius Medical Care AG (FMG) on Tuesday unveiled its FME Reignite strategy at its Capital Markets Day in London, outlining a roadmap for value creation through three pillars, namely Reignite the Core, Reignite Growth and In... Full story

Yahoo Finance • 8 months ago

Fresenius Medical Care First Quarter 2025 Earnings: EPS: €0.52 (vs €0.24 in 1Q 2024)

Fresenius Medical Care (ETR:FME) First Quarter 2025 Results Key Financial Results Revenue: €4.88b (up 3.3% from 1Q 2024). Net income: €151.0m (up 113% from 1Q 2024). Profit margin: 3.1% (up from 1.5% in 1Q 2024). The increase in margin w... Full story

Yahoo Finance • 9 months ago

Is Fresenius Medical Care AG (FMS) the Most Undervalued Healthcare Stock to Buy According to Analysts?

We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Fresenius Medical Care AG (NYSE:FMS) stands against other most undervalued healthcare... Full story

Yahoo Finance • last year

Fresenius Medical Care (ETR:FME) earnings and shareholder returns have been trending downwards for the last three years, but the stock advances 4.8% this past week

As an investor its worth striving to ensure your overall portfolio beats the market average. But its virtually certain that sometimes you will buy stocks that fall short of the market average returns. We regret to report that long term Fre... Full story

Yahoo Finance • 2 years ago

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q1 2024 Earnings Call Transcript

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q1 2024 Earnings Call Transcript May 7, 2024 Fresenius Medical Care AG & Co. KGaA beats earnings expectations. Reported EPS is $0.36, expectations were $0.26. Fresenius Medical Care AG & Co.... Full story